On Jan. 24, 2017, Ontario-based Loyalist College announced that it had been approved by Health Canada for a Controlled Drugs and Substances Licence to test and analyze medical cannabis.
“Loyalist College is proud to play an important role in the research and development of safe and effective phytomedicinal products,” said Ann Marie Vaughan, President & CEO of Loyalist College. “In partnership with Health Canada and industry leaders, we will help to inform related decision making, continuous quality improvement and sustainable practices. Increased R&D in this area is timely and essential moving forward.”
Dr. Kari Kramp, a Biosciences Professor in Loyalist College’s Supercritical CO2 Extraction Applied Research Laboratory, will lead the college’s medical cannabis research.
“What the consumers want to know is what exactly is in it — if they’re looking for CBD or they’re looking for THC,” said Kramp in an interview with Quinte News. “In addition, it’s important from a safety and a quality perspective for consumers and producers to acknowledge that there’s no contaminants.”